Eli Lilly Corp. buy Argus
Start price
13.02.26
/
50%
€888.30
Target price
13.02.27
€1,011.0
Performance (%)
-9.82%
Price
10.04.26
€801.10
Summary
This prediction is currently active. With a performance of -9.82%, the BUY prediction for Eli Lilly Corp. by Argus is down slightly. This prediction currently runs until 13.02.27. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.269% | -1.269% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Argus for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Argus from $930.00 to $1,200.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Argus for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€703.10
14.05.24
14.05.24
€776.16
14.05.25
14.05.25
-8.83%
15.05.25
15.05.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€520.50
05.09.23
05.09.23
€578.15
05.09.24
05.09.24
57.33%
06.09.24
06.09.24